A researcher with the University of Arkansas for Medical Sciences (UAMS) received a National Cancer Institute grant for over $1.7 million to study ways bone therapy can possibly repair damaged bone and stop or delay relapse in myeloma patients. The study is led by...
Cancer
Category
University of Louisville Secures $11.5m Grant from NIGMS to Establish Center for Cancer Immunology and Immunotherapy (CCII)
The University of Louisville was recognized for its over two decades of success in cancer research and is now poised to advance immunotherapy with a grant of $11.5 million from the National Institute of General Medical Sciences. The funds will go toward the...
Gilead Closer to Spending $20b to Acquire Immunomedics
Gilead is purportedly going to spend $20 billion to acquire Immunomedics, reports the Wall Street Journal. With an investigational product in the late-stage producing positive data last month, the company just benefited from an U.S. Food and Drug Administration...
NCI & Cancer Research UK Partner to Drive Innovate New Cancer Research
In what can only be considered an exciting move in the world of cancer research, the United States’ national research institute—the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), formed a partnership with the United Kingdom’s Cancer...
Beaumont Health Participates in National Study Identifying the Impacts of COVID-19 on Cancer Patients
Researchers, led by Dr. Dana Zakalik, professor of medicine and oncology at the Oakland University William Beaumont School of Medicine secured participation in a National Cancer Institute (NCI) COVID-19 clinical trial, a national study investigating the impact of...
OneOncology and Foundation Medicine Unveil First-of-its-Kind Partnership to Advance Personalized Medicine at Community Oncology Practices
Foundation Medicine, Inc. and OneOncology announced today, August 17th, 2020, a new joint initiative that is intended to better enable OneOncology partner practice physicians to unlock the potential of precision oncology through comprehensive genomic profiling (CGP)...
Einstein, Montefiore & Rutgers Secure $4.6m NIH Grant to Launch Study to Help ALL Children Receiving Chemo
A research team led by Albert Einstein College of Medicine, Children’s Hospital at Montefiore (CHAM) and Rutgers Cancer Institute of New Jersey have secured a five-year, $4.6 million grant from the National Institutes of Health (NIH) to...
Balance of Risks: COVID-19 Focus Costing Lives in Cancer Care
On July 19, the American Journal of Managed Care published an article suggesting that our focus on COVID-19 could result in greater cancer mortality. The report focuses on a talk by with Dr. Ned Sharpless, director of the National Cancer Institute (NCI), at the...
Cancer Research as a Care Option Comes to the Upper Midwest with Avera Cancer Institute
Avera Health, a regional health system based in Sioux Falls, SD, includes over 300 locations in 100 communities throughout South Dakota, Minnesota, Iowa, Nebraska and North Dakota (or what can be considered the Upper Midwest or within the Great Plains of the United...
Hoag Offers Breakthrough Clinical Trial for Pancreatic Cancer Patients
Hoag has been exclusively selected as the only hospital in Orange County, and the only non-academic institution, to offer this promising phase 2 immunotherapy clinical trial for solid tumors. Hoag’s commitment to innovation and excellence has earned the hospital...
OneOncology Expands to Southern California with the Los Angeles Cancer Network Joining the Platform for a Win-Win
OneOncology incorporated yet another community oncology provider, Los Angeles Cancer Network (LACN), into its growing network nationwide. This private equity-based group is developing an important model. OneOncology, on the one hand, seeks to embrace the realities of...
Cedric the Entertainer & SUTC Promote Research Awareness to Minority Populations Disproportionately Impacted by Cancer
Stand Up to Cancer (SU2C), a non-profit organization out of Hollywood entertainment world that supports cancer research, recently teamed with Cedric the Entertainer to bring more awareness of cancer research to People of Color, including African Americans. The star of...
Pan-Bcl-2 (navitoclax) or Bcl-xL-specific inhibitor drugs Can do More Damage in Oncology Combos
A research team led by Norwegian University of Science and Technology have concluded from an ongoing study that certain types of drugs that can kill cells can do more harm than good when used in combination with other cancer treatments. They took on an investigational...
NCI Renews Huntsman Cancer Institute Prestigious Designated Comprehensive Cancer Center Status: $29m & Near Perfect Ranking
Huntsman Cancer Institute (HCI) actually provides cancer research to nearly 20% of the lower 48 states of America, meaning that those that live in a massive section of the Intermountain West, from Wyoming, Montana and Idaho to Utah, eastern Nevada and western...
UCSD Health Moores Cancer Center Saving Lives During Pandemic with Clinical Trials
1,600 people die of cancer every day in America. For many cancer patients, a clinical trial represents the only hope for survival. COVID-19 has imminently threatened the lives of tens of thousands of people (if not more) that rely on clinical trials to face...
Immunotherapy Safe for Cancer Patients with COVID-19
Preliminary data from researchers at the University of Cincinnati Cancer Center show that immunotherapy doesn't necessarily worsen complications for patients with both COVID-19 and cancer. This data was presented by Layne Weatherford, PhD, UC postdoctoral fellow, at...
The Loss of Logan Must Lead to A Greater Commitment to R&D into Pediatric Diffuse Intrinsic Pontine Glioma (“DIPG”)
More funding needs to go into pediatric diffuse intrinsic pontine glioma or “DIPG,” an untreatable brain cancer. When stories of three-year old children losing their life to such a condition surface, TrialSite News springs to action directing supporters to the family...
Oncology Research Patients: No Longer a Need to Cross the Bridge into Manhattan for Superior Cancer Treatment
Private equity-backed OneOncology is on the move again as a leading national cancer practice, New York Cancer & Blood Specialists (NYCBS), inked a partnership deal with The Brooklyn Hospital Center (TBHC), an independent community hospital in the quest to build a...
Top Oncology Investigator Dr. Anthony Tolcher (Next Oncology) Selected by Heat Biologics to Lead Novel Phase I Oncology Study
Anthony Tolcher, MD, FRCPC, a medical oncologist and co-founder of research organization NEXT Oncology has been appointed the lead investigator for a Phase I clinical trial investigating Heat Biologics’ investigational therapy called PTX-35, a novel potential...
‘It Must be Witchcraft’ as Harry M Reid’s Life Saved by Combination Therapy Delivered by the ‘Unconventional’ Dr. Patrick Soon-Shiong
At 80 years old, former U.S. Senator Harry M. Reid’s struggle with pancreatic cancer was close to the end. But the ex-boxer and hard-scrabble fighter that he is propelled him to survive despite the extremely low odds: he is now spending time with his adult children...